B. G. Susan Robinson
Geen lopende functies
Profiel
B.
G.
Susan Robinson has been President and Chief Executive Officer of Targeted Genetics Corp.
since November 6, 2008 and a Director since November 14, 2008.
Prior to Targeted Genetics, she was Director-Business Development of Genzyme Molecular Oncology.
Ms. Robinson held various positions for Immulogic Pharmaceuticals Corporation and T-Cell Sciences, Inc. She received a degree from Yale University.
Eerdere bekende functies van B. G. Susan Robinson
| Bedrijven | Functie | Einde |
|---|---|---|
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | President | - |
Opleiding van B. G. Susan Robinson
| Yale University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
